Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4130236
Max Phase: Preclinical
Molecular Formula: C30H50N4S2
Molecular Weight: 530.89
Molecule Type: Small molecule
Associated Items:
ID: ALA4130236
Max Phase: Preclinical
Molecular Formula: C30H50N4S2
Molecular Weight: 530.89
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: S=C(NCCCCCCCCNC(=S)NC12CC3CC(CC(C3)C1)C2)NC12CC3CC(CC(C3)C1)C2
Standard InChI: InChI=1S/C30H50N4S2/c35-27(33-29-15-21-9-22(16-29)11-23(10-21)17-29)31-7-5-3-1-2-4-6-8-32-28(36)34-30-18-24-12-25(19-30)14-26(13-24)20-30/h21-26H,1-20H2,(H2,31,33,35)(H2,32,34,36)
Standard InChI Key: ZKQUPMKECRYQAG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 530.89 | Molecular Weight (Monoisotopic): 530.3477 | AlogP: 6.19 | #Rotatable Bonds: 11 |
Polar Surface Area: 48.12 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 4 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.87 | CX Basic pKa: | CX LogP: 6.31 | CX LogD: 6.31 |
Aromatic Rings: 0 | Heavy Atoms: 36 | QED Weighted: 0.19 | Np Likeness Score: -0.46 |
1. Burmistrov V, Morisseau C, Pitushkin D, Karlov D, Fayzullin RR, Butov GM, Hammock BD.. (2018) Adamantyl thioureas as soluble epoxide hydrolase inhibitors., 28 (13): [PMID:29803731] [10.1016/j.bmcl.2018.05.024] |
Source(1):